TNGX stock

Tango Therapeutics Inc (TNGX) financials · rev $62.4M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Tango Therapeutics Inc (TNGX) rev $62.4M.

Cached annual income statement
LineFY2025FY2024
Revenue$62.4M$42.1M
Operating Income-$111.3M-$145.6M
Net Income-$101.6M-$130.3M
EPS (Diluted)-$0.87-$1.19
Cached annual balance sheet
LineFY2025FY2024
Total Assets$398.7M$316.5M
Current Assets$353.8M$266.3M
Cash & Equivalents$112.3M$69.5M
PP&E$6.87M$8.10M
Total Liabilities$52.5M$117.0M
Current Liabilities$21.7M$38.2M
Shareholders' Equity$346.2M$199.5M
Retained Earnings-$603.2M-$501.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$138.9M-$131.5M
CapEx$1.05M$754.0K
Investing Cash Flow-$40.9M$86.1M
Financing Cash Flow$222.5M$47.7M
Net Change in Cash$42.7M$2.29M
Free Cash Flow-$139.9M-$132.3M
These statements as JSON? API free 100/day

FAQ

What is TNGX P/E and revenue?

Tango Therapeutics Inc (TNGX) rev $62.4M.

What is TNGX revenue?

Tango Therapeutics Inc last cached revenue is $62.4M (FY2025).

Is TNGX profitable?

Tango Therapeutics Inc last cached net income is -$101.6M (FY2025).

What are TNGX total assets?

Tango Therapeutics Inc last cached total assets are $398.7M (FY2025).

What is TNGX free cash flow?

Tango Therapeutics Inc last cached free cash flow is -$139.9M (FY2025).

Not investment advice. Cached statements, not a live tape.